These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35120363)

  • 41. Clobetasol propionate spray 0.05% add-on therapy to a stable regimen of biologic treatment in patients with moderate to very severe plaque psoriasis.
    Feldman SR; Koo JY; Johnson LA; Preston NJ
    Cutis; 2009 Oct; 84(4 Suppl):25-32. PubMed ID: 19916299
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Advances in Psoriasis.
    Smith J; Cline A; Feldman SR
    South Med J; 2017 Jan; 110(1):65-75. PubMed ID: 28052180
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Childhood psoriasis].
    Mahé E; Gnossike P; Sigal ML
    Arch Pediatr; 2014 Jul; 21(7):778-86. PubMed ID: 24935452
    [TBL] [Abstract][Full Text] [Related]  

  • 44. S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update.
    Nast A; Boehncke WH; Mrowietz U; Ockenfels HM; Philipp S; Reich K; Rosenbach T; Sammain A; Schlaeger M; Sebastian M; Sterry W; Streit V; Augustin M; Erdmann R; Klaus J; Koza J; Muller S; Orzechowski HD; Rosumeck S; Schmid-Ott G; Weberschock T; Rzany B; ;
    J Dtsch Dermatol Ges; 2012 Mar; 10 Suppl 2():S1-95. PubMed ID: 22386073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of topical therapies along the psoriasis patient journey: An overview from the Symposium 'Tailoring topical psoriasis treatments to patients' needs and expectations' of the 30
    Pinter A; van de Kerkhof P
    J Eur Acad Dermatol Venereol; 2023 Jan; 37 Suppl 1():3-8. PubMed ID: 36546464
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systemic treatment for moderate to severe psoriasis: estimates of failure rates and direct medical costs in a north-eastern US managed care plan.
    Feldman SR; Evans C; Russell MW
    J Dermatolog Treat; 2005 Feb; 16(1):37-42. PubMed ID: 15897166
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biologics for the primary care physician: Review and treatment of psoriasis.
    Schadler ED; Ortel B; Mehlis SL
    Dis Mon; 2019 Mar; 65(3):51-90. PubMed ID: 30037762
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interventions for chronic palmoplantar pustulosis.
    Obeid G; Do G; Kirby L; Hughes C; Sbidian E; Le Cleach L
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011628. PubMed ID: 31958161
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effectiveness of systemic treatment agents on psoriatic nails: a comparative study.
    Demirsoy EO; Kıran R; Salman S; Cağlayan C; Aktürk AS; Bayramgurler D; Bilen N
    J Drugs Dermatol; 2013 Sep; 12(9):1039-43. PubMed ID: 24002153
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combination regimens of topical calcipotriene in chronic plaque psoriasis: systematic review of efficacy and tolerability.
    Ashcroft DM; Li Wan Po A; Williams HC; Griffiths CE
    Arch Dermatol; 2000 Dec; 136(12):1536-43. PubMed ID: 11115167
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ultraviolet B Phototherapy for Psoriasis: Review of Practical Guidelines.
    Mehta D; Lim HW
    Am J Clin Dermatol; 2016 Apr; 17(2):125-33. PubMed ID: 26872953
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Update on pediatric psoriasis, Part 2: Therapeutic management.
    Silverberg NB
    Cutis; 2010 Oct; 86(4):172-6. PubMed ID: 21140923
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Asian consensus on assessment and management of mild to moderate plaque psoriasis with topical therapy.
    Imafuku S; Zheng M; Tada Y; Zhang X; Theng C; Thevarajah S; Zhao Y; Song HJ
    J Dermatol; 2018 Jul; 45(7):805-811. PubMed ID: 29740870
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Childhood psoriasis.
    Benoit S; Hamm H
    Clin Dermatol; 2007; 25(6):555-62. PubMed ID: 18021892
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rationale, objectives and design of PURE, a prospective registry of patients with moderate to severe chronic plaque psoriasis in Canada and Latin America.
    Papp KA; Gooderham M; Beecker J; Lynde CW; Delorme I; Dei-Cas I; Albrecht L; Rampakakis E; Sampalis JS; Vieira A; Hussein S; Chambenoit O; Rihakova L
    BMC Dermatol; 2019 Jun; 19(1):9. PubMed ID: 31226985
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral PSORI-CM01, a Chinese herbal formula, plus topical sequential therapy for moderate-to-severe psoriasis vulgaris: pilot study for a double-blind, randomized, placebo-controlled trial.
    Yao DN; Lu CJ; Wen ZH; Yan YH; Xuan ML; Li XY; Li G; He ZH; Xie XL; Deng JW; Guo XF; Ou AH
    Trials; 2016 Mar; 17(1):140. PubMed ID: 26983642
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of Phototherapy Guidelines for Psoriasis: A Critical Appraisal and Comprehensive Review.
    Vassantachart JM; Soleymani T; Wu JJ
    J Drugs Dermatol; 2016 Aug; 15(8):995-1000. PubMed ID: 27538001
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Back to the future: a new topical approach for mild-to-moderate psoriasis.
    Girolomoni G; Calzavara Pinton P; Cristaudo A; Cicchetti A
    G Ital Dermatol Venereol; 2018 Jun; 153(3):375-382. PubMed ID: 27982547
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapy of moderate and severe psoriasis.
    Claes C; Kulp W; Greiner W; von der Schulenburg JM; Werfel T
    GMS Health Technol Assess; 2006 Apr; 2():Doc07. PubMed ID: 21289958
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcomes associated with the use of biologic agents in moderate to severe psoriasis.
    Price J; Bhosle M; Feldman SR; Balkrishnan R
    J Drugs Dermatol; 2007 Mar; 6(3):259-67. PubMed ID: 17373187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.